9002 N. Meridian St. Ste. 205, Indianapolis, IN 46260
GLP-1 & Tirzepatide Weight Management at Chernoff Cosmetic Surgery
GLP-1 receptor agonists (like Semaglutide) and Tirzepatide are proven prescription medications that support medical weight management by reducing appetite, slowing gastric emptying, and improving insulin sensitivity. Chernoff Cosmetic Surgery now offers these therapies in collaboration with DrWell to provide evidence-based metabolic care as part of a comprehensive wellness plan.
How These Medications Work
- GLP-1 agonists act on gut-brain signaling to reduce hunger and help control blood sugar.
- Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines appetite suppression with enhanced metabolic effects such as improved insulin sensitivity and energy use.
- Combination approaches that use multiple agonists (sometimes compounded as GLP-1²) can target complementary pathways for greater metabolic benefit when clinically appropriate.
What to Expect During Treatment
- An initial, complimentary consultation is required to review medical history, goals, and baseline labs; a medication plan is prescribed only when safe and appropriate.
- Medications are typically administered via once-weekly subcutaneous injection and titrated based on tolerance and clinical response.
- Most patients combine medication with dietary, lifestyle, and follow-up clinical support to maximize outcomes and monitor safety.
Benefits
- Meaningful, clinically supported weight reduction for many patients when used with lifestyle changes.
- Improvements in appetite control, blood sugar regulation, and metabolic health markers.
Safety & Side Effects
These medications are prescription treatments and carry potential side effects (commonly gastrointestinal symptoms during dose escalation). Careful medical screening, monitoring, and dose adjustments reduce risk and improve tolerability. For safety, a prescribing clinician will review your full medical history and any medications before initiating therapy. For general drug information and side-effect profiles, see established clinical resources.
Treatment Options We Offer
- Semaglutide (GLP-1 options) — for appetite regulation and glucose control.
- Tirzepatide — dual-action agent that targets both GIP and GLP-1 pathways for enhanced metabolic effect.
- Compounded dual formulations (GLP-1²) — available when a prescriber determines a combined approach is clinically appropriate.
Who May Be a Candidate
Candidates are adults who would benefit from supervised medical weight management and who have undergone a clinical evaluation. Individual suitability depends on medical history, current medications, and personal goals — all assessed during a consultation.
Frequently Asked Questions
Do I need labs or tests first?
Yes — baseline labs and a medical review help ensure therapy is safe and appropriate for you.
How soon will I see results?
Many patients notice appetite reduction early in the titration phase; measurable weight changes typically occur over weeks to months under a supervised plan.
Are these the same medications used for diabetes?
Some GLP-1 agents and Tirzepatide are used to treat type 2 diabetes; when prescribed for weight management, dosing and monitoring follow current clinical guidelines.
How is this different than Wegovy and Ozempic?
It is the same compound, Semaglutide, which is technically a GLP-1 agonist. Dr. Well uses a compounding pharmacy differing from a pharmaceutical drug company using their personal labs and pharmacies.
Where does the medication come from?
The medication is made by Dr. Well
Who is not a canidate for Semaglutide?
- History of thyroid condition
- History of pancreatitis
- If BMI is less than 30 or 27 for those with weight-related medical conditions such as hypertension, diabetes, knee pain, etc.)
Schedule a Consultation
Chernoff Cosmetic Surgery provides these therapies in partnership with DrWell to deliver safe, effective medical weight management in our office. To learn more or schedule a complimentary consultation, call our Indianapolis office at (317) 573-8899 or request an appointment online.